ProShare Advisors
TWST icon

ProShare Advisors’s Twist Bioscience TWST Stock Holding History

ProShare Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
10,174
-1,352
-12% -$88K ﹤0.01% 790
2026
Q1 		$548K Sell
11,526
-2,110
-15% -$94.6K ﹤0.01% 1008
2025
Q4 		$433K Buy
13,636
+1,375
+11% +$42.9K ﹤0.01% 1215
2025
Q3 		$345K Sell
12,261
-2,103
-15% -$63.7K ﹤0.01% 1326
2025
Q2 		$528K Sell
14,364
-1,160
-7% -$40.1K ﹤0.01% 1095
2025
Q1 		$609K Sell
15,524
-3,702
-19% -$167K ﹤0.01% 991
2024
Q4 		$893K Buy
19,226
+4,488
+30% +$203K ﹤0.01% 971
2024
Q3 		$666K Buy
14,738
+2,990
+25% +$142K ﹤0.01% 969
2024
Q2 		$579K Sell
11,748
-2,696
-19% -$110K ﹤0.01% 902
2024
Q1 		$496K Buy
14,444
+1,336
+10% +$48.2K ﹤0.01% 1088
2023
Q4 		$483K Buy
13,108
+1,962
+18% +$45.4K ﹤0.01% 1054
2023
Q3 		$226K Buy
11,146
+46
+0.4% +$1.01K ﹤0.01% 1387
2023
Q2 		$227K Buy
11,100
+481
+5% +$7.21K ﹤0.01% 1456
2023
Q1 		$160K Sell
10,619
-1,283
-11% -$28.3K ﹤0.01% 1503
2022
Q4 		$283K Buy
11,902
+972
+9% +$28.2K ﹤0.01% 1273
2022
Q3 		$385K Sell
10,930
-680
-6% -$28.9K ﹤0.01% 1011
2022
Q2 		$406K Sell
11,610
-5,812
-33% -$206K ﹤0.01% 1030
2022
Q1 		$860K Sell
17,422
-1,097
-6% -$60.8K ﹤0.01% 978
2021
Q4 		$1.43M Buy
18,519
+778
+4% +$79.9K ﹤0.01% 872
2021
Q3 		$1.9M Sell
17,741
-3,292
-16% -$377K 0.01% 728
2021
Q2 		$2.8M Buy
21,033
+1,764
+9% +$205K 0.01% 651
2021
Q1 		$2.39M Buy
19,269
+5,056
+36% +$768K 0.01% 643
2020
Q4 		$2.01M Buy
14,213
+3,006
+27% +$333K 0.01% 635
2020
Q3 		$851K Buy
11,207
+600
+6% +$37.4K ﹤0.01% 770
2020
Q2 		$480K Buy
+10,607
New +$381K ﹤0.01% 965
2020
Q1 		– Sell
-10,091
Closed -$212K – 1567
2019
Q4 		$212K Buy
+10,091
New +$236K ﹤0.01% 1553

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

ProShare Advisors's TWST Position: Q2 2026 in Review

ProShare Advisors reduced its Twist Bioscience (TWST) stake by 12% in Q2 2026, selling an estimated $88K and leaving 10,174 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #790.

ProShare Advisors first reported a position in TWST in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.8M in Q2 2021. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • ProShare Advisors held 10,174 shares of Twist Bioscience worth $1.05M as of Q2 2026.
  • ProShare Advisors sold 1,352 Twist Bioscience shares in Q2 2026, an estimated $88K.
  • Twist Bioscience made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #790 holding.
  • ProShare Advisors first reported a position in Twist Bioscience in Q4 2019 and has held it in 26 quarters since.
  • ProShare Advisors's Twist Bioscience position peaked at $2.8M in Q2 2021.
  • 336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.